HPWM
IHE icon

High Point Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

High Point Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Hold
153
– – 0.01% 201
2026
Q1 		$13.3K Buy
153
+1
+0.7% +$88 0.01% 203
2025
Q4 		$12.9K Buy
+152
New +$12.1K 0.01% 205

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

High Point Wealth Management's IHE Position: Q2 2026 in Review

High Point Wealth Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 153 shares worth $15.2K. The position accounts for 0.01% of the portfolio, ranked #201.

High Point Wealth Management first reported a position in IHE in Q4 2025 and has held it in 3 quarters since. 120 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • High Point Wealth Management held 153 shares of iShares US Pharmaceuticals ETF worth $15.2K as of Q2 2026.
  • High Point Wealth Management left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up 0.01% of High Point Wealth Management's portfolio in Q2 2026, its #201 holding.
  • High Point Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • 120 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on High Point Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.